Atlas Trials

Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT02046421 · COMPLETED

Trial details

NCT number
NCT02046421
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Male Breast CancerRecurrent Breast CancerRecurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast Cancer
Start date
2013-11-01
Primary completion
2018-05-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.